Literature DB >> 20165915

Collaborative problem solving (CPS) as a primary method of addressing acute pediatric pathological aggression along with other modalities.

Gaurav Kulkarni1, Parikshit Deshmukh, Drew Barzman.   

Abstract

The answer for treating pathologic aggression (PA) in children on inpatient psychiatry units (based on various factors like severity of aggression and co-morbidities) is less likely to be restrictive interventions or sedating the patient. Using seclusion and restraints or medications to calm down the aggression is not free of adverse consequences. A protocol is needed to safely and effectively address aggressive and violent children and adolescents seen very commonly in psychiatry inpatient units.

Entities:  

Mesh:

Year:  2010        PMID: 20165915     DOI: 10.1007/s11126-010-9126-2

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  24 in total

1.  A naturalistic evaluation of intramuscular ziprasidone versus intramuscular olanzapine for the management of acute agitation and aggression in children and adolescents.

Authors:  Shamima S Khan; Lisa M Mican
Journal:  J Child Adolesc Psychopharmacol       Date:  2006-12       Impact factor: 2.576

2.  Behavioral efficacy of haloperidol and lithium carbonate. A comparison in hospitalized aggressive children with conduct disorder.

Authors:  M Campbell; A M Small; W H Green; S J Jennings; R Perry; W G Bennett; L Anderson
Journal:  Arch Gen Psychiatry       Date:  1984-07

3.  A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder.

Authors:  R P Malone; M A Delaney; J F Luebbert; J Cater; M Campbell
Journal:  Arch Gen Psychiatry       Date:  2000-07

4.  Innovations: child & adolescent psychiatry: use of collaborative problem solving to reduce seclusion and restraint in child and adolescent inpatient units.

Authors:  Ross W Greene; J Stuart Ablon; Bruce Hassuk; Kathleen M Regan; Andrés Martin
Journal:  Psychiatr Serv       Date:  2006-05       Impact factor: 3.084

Review 5.  The use of seclusion is not evidence-based practice.

Authors:  L M Finke
Journal:  J Child Adolesc Psychiatr Nurs       Date:  2001 Oct-Dec

Review 6.  A transactional model of oppositional behavior: underpinnings of the Collaborative Problem Solving approach.

Authors:  Ross W Greene; J Stuart Ablon; Jennifer C Goring
Journal:  J Psychosom Res       Date:  2003-07       Impact factor: 3.006

Review 7.  Pharmacological treatment of pathologic aggression in children.

Authors:  Drew H Barzman; Robert L Findling
Journal:  Int Rev Psychiatry       Date:  2008-04

8.  A retrospective chart review of intramuscular ziprasidone for agitation in children and adolescents on psychiatric units: prospective studies are needed.

Authors:  Drew H Barzman; Melissa P DelBello; Jacob J Forrester; Paul E Keck; Stephen M Strakowski
Journal:  J Child Adolesc Psychopharmacol       Date:  2007-08       Impact factor: 2.576

9.  A prospective study of assault against staff by youths in a state psychiatric hospital.

Authors:  Eileen P Ryan; Virginia Sparrow Hart; Deborah L Messick; Jeffrey Aaron; Mandi Burnette
Journal:  Psychiatr Serv       Date:  2004-06       Impact factor: 3.084

10.  Conventional intramuscular sedatives versus ziprasidone for severe agitation in adolescents: case-control study.

Authors:  William C Jangro; Horacio Preval; Robert Southard; Steven G Klotz; Andrew Francis
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2009-03-12       Impact factor: 3.033

View more
  2 in total

1.  Risk Factors for Seclusion and Restraint in a Pediatric Psychiatry Day Hospital.

Authors:  Wuroh Timbo; Aishwarya Sriram; Elizabeth K Reynolds; Renee DeBoard-Lucas; Matthew Specht; Carolyn Howell; Colleen McSweeney; Marco A Grados
Journal:  Child Psychiatry Hum Dev       Date:  2016-10

2.  Frequency, characteristics and management of adolescent inpatient aggression.

Authors:  Immaculada Baeza; Christoph U Correll; Ema Saito; Dinara Amanbekova; Meena Ramani; Sandeep Kapoor; Raja Chekuri; Marc De Hert; Maren Carbon
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-05-06       Impact factor: 2.576

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.